SCHEMBL7107871

SCHEMBL7107871

CC(=O)ONC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 9/20 0.49
CCR5 P51681 3/20 0.49
ADRB2 P07550 1/20 0.48
HRH1 P35367 1/20 0.48
DRD3 P35462 1/20 0.48
GLP1R P43220 1/20 0.48
FFAR4 Q5NUL3 1/20 0.48
GPR119 Q8TDV5 1/20 0.48
NPSR1 Q6W5P4 1/20 0.45
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
PKM P14618 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
MAPK1 P28482 1/20 0.39
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
CFTR P13569 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13043839 0.84 CCR2 (0.50) CCR2CCR5ADRB2HRH1DRD3
SCHEMBL5741416 0.83 CCR2 (0.49) CCR2CCR5ADRB2HRH1DRD3
SCHEMBL2080677 0.81 CCR2 (0.50) CCR2CCR5ADRB2HRH1DRD3
SCHEMBL7106212 0.80 RXFP1 (0.55) CCR2KDM4ECYP2C19CFTRRXFP1
SCHEMBL2993504 0.79 CCR2 (0.61) CCR2CCR5ADRB2HRH1DRD3
SCHEMBL14014922 0.77 MEN1 (0.50) CCR2CCR5ADRB2HRH1DRD3
SCHEMBL2079560 0.77 CCR2 (0.45) CCR2CCR5ADRB2HRH1DRD3
SCHEMBL24263353 0.73 MEN1 (0.57) NPSR1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL12885976 0.73 MEN1 (0.53) CCR2CCR5NPSR1MEN1KMT2A
SCHEMBL13753370 0.73 CES2 (0.60) NPSR1KDM4ESMN1; SMN2MRGPRX4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1343751-A2 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2003-09-17 EP disclosed
WO-2002060859-A2 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2002-08-08 WO disclosed